Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)
China flag China · Delayed Price · Currency is CNY
207.61
+0.48 (0.23%)
May 9, 2025, 2:45 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Liver Disease Medication
4.46B
Log In
Log In
Log In
Log In
Liver Disease Medication Growth
24.26%
Log In
Log In
Log In
Log In
Pharmaceutical Circulation
4.20B
Log In
Log In
Log In
Log In
Pharmaceutical Circulation Growth
3.60%
Log In
Log In
Log In
Log In
Cosmetics
706.76M
Log In
Log In
Log In
Log In
Cosmetics Growth
11.42%
Log In
Log In
Log In
Log In
Cardiovascular and Cerebrovascular Medication
265.75M
Log In
Log In
Log In
Log In
Cardiovascular and Cerebrovascular Medication Growth
60.57%
Log In
Log In
Log In
Log In
Other Business
22.31M
Log In
Log In
Log In
Log In
Other Business Growth
14.28%
Log In
Log In
Log In
Log In
Other
395.59M
Log In
Log In
Log In
Log In
Other Growth
76.53%
Log In
Log In
Log In
Log In
Pharmaceutical
-
Log In
Log In
Log In
Log In
Pharmaceutical Growth
-
Log In
Log In
Log In
Log In
Cosmetics and Daily Chemical
-
Log In
Log In
Log In
Log In
Cosmetics and Daily Chemical Growth
-
Log In
Log In
Log In
Log In
Food
-
Log In
Log In
Log In
Log In
Food Growth
-
Log In
Log In
Log In
Log In
Respiratory System Medication
-
Log In
Log In
Log In
Log In
Respiratory System Medication Growth
-
Log In
Log In
Log In
Log In
Dermatology Medication
-
Log In
Log In
Log In
Log In
Dermatology Medication Growth
-
Log In
Log In
Log In
Log In
Cold Medicine
-
Log In
Log In
Log In
Log In
Cold Medicine Growth
-
Log In
Log In
Log In
Log In
Orthopedics Medicines
-
Log In
Log In
Log In
Log In
Anorectal Medicine
-
Log In
Log In
Log In
Log In
Anorectal Medicine Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
China
9.60B
Log In
Log In
Log In
Log In
China Growth
15.78%
Log In
Log In
Log In
Log In
Overseas
457.64M
Log In
Log In
Log In
Log In
Overseas Growth
13.95%
Log In
Log In
Log In
Log In